Active ingredient
Ioversol
7 finished FDA listings contain Ioversol as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- IOVERSOL
- Dosage forms
- Injection
- Routes
- Intra-Arterial, Intravenous
- Manufacturers / labelers
- 1
- Strengths listed
- 636 mg/ml · 678 mg/ml · 741 mg/ml
- Brand names in FDA listings
- Optiray 300, Optiray 320, Optiray 350
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 27792
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 019710 | LIEBEL-FLARSHEIM | 1988-12-30 | 3 |
| NDA 020923 | LIEBEL-FLARSHEIM | 1998-05-29 | 4 |
Official labeling on DailyMed
- OPTIRAY 350 (IOVERSOL) INJECTION OPTIRAY 320 (IOVERSOL) INJECTION OPTIRAY 300 (IOVERSOL) INJECTION [LIEBEL-FLARSHEIM COMPANY LLC] · version 39 · 2025-12-31
- OPTIRAY 350 (IOVERSOL) INJECTION OPTIRAY 320 (IOVERSOL) INJECTION OPTIRAY 300 (IOVERSOL) INJECTION [LIEBEL-FLARSHEIM COMPANY LLC] · version 7 · 2025-12-31
- OPTIRAY 350 (IOVERSOL) INJECTION OPTIRAY 320 (IOVERSOL) INJECTION OPTIRAY 300 (IOVERSOL) INJECTION [LIEBEL-FLARSHEIM COMPANY LLC] · version 50 · 2023-06-06
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.